المؤلفون: Zancanella P; Center for Molecular Genetics and Cancer Research-CEGEMPAC, Department of Pediatrics, Federal University of Paraná, and Division of Pediatric Oncology, Erasto Gaertner Hospital, Liga Paranaense de Combate ao Câncer, Curitiba, PR, CEP, Brazil., Pianovski MA, Oliveira BH, Ferman S, Piovezan GC, Lichtvan LL, Voss SZ, Stinghen ST, Callefe LG, Parise GA, Santana MH, Figueiredo BC

المصدر: Journal of pediatric hematology/oncology [J Pediatr Hematol Oncol] 2006 Aug; Vol. 28 (8), pp. 513-24.

نوع المنشور: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9505928 Publication Model: Print Cited Medium: Print ISSN: 1077-4114 (Print) Linking ISSN: 10774114 NLM ISO Abbreviation: J Pediatr Hematol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Adrenal Cortex Neoplasms/*drug therapy , Adrenocortical Carcinoma/*drug therapy , Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Cisplatin/*administration & dosage , Doxorubicin/*administration & dosage , Etoposide/*administration & dosage , Mitotane/*administration & dosage, Administration, Oral ; Adrenal Cortex Neoplasms/diagnosis ; Adrenal Cortex Neoplasms/surgery ; Adrenocortical Carcinoma/diagnosis ; Adrenocortical Carcinoma/surgery ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Child ; Child, Preschool ; Cisplatin/adverse effects ; Disease Progression ; Dose-Response Relationship, Drug ; Doxorubicin/adverse effects ; Drug Administration Schedule ; Drug Monitoring/methods ; Drug Therapy, Combination ; Etoposide/adverse effects ; Female ; Follow-Up Studies ; Humans ; Male ; Mitotane/adverse effects ; Neoplasm Staging ; Prospective Studies ; Remission Induction ; Survival Rate ; Time Factors ; Treatment Outcome